Advertisement

Topics

QIDP status granted to Spero's UTI, bacterial pneumonia candidate

05:56 EDT 12 Oct 2018 | SmartBrief

Spero Therapeutics' SPR206, being developed to treat patients with hospital-acquired bacterial pneumonia, ventilator-associat -More

Original Article: QIDP status granted to Spero's UTI, bacterial pneumonia candidate

NEXT ARTICLE

More From BioPortfolio on "QIDP status granted to Spero's UTI, bacterial pneumonia candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pneumonia
Pneumonia (bronchopneumonia, lobar pneumonia and double pneumonia) is inflammation (swelling) of the tissue in one or both of your lungs. It is usually caused by an pneumococcal infection caused by bacteria called Streptococcus pneumoniae.  However,...